Effects of a neuregulin 1 variant on conversion to schizophrenia and schizophreniform disorder in people at high risk for psychosis

This publication has 9 references indexed in Scilit:

• A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms
  Nature Neuroscience, 2006
• Neuregulin 1 (8p12) and childhood-onset schizophrenia: susceptibility haplotypes for diagnosis and brain developmental trajectories
  Molecular Psychiatry, 2006
• Association of Neuregulin 1 with schizophrenia and bipolar disorder in a second cohort from the Scottish population
  Molecular Psychiatry, 2006
• Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5′ SNPs associated with the disease
  Proceedings of the National Academy of Sciences, 2006
• Use of real-time PCR for determining copy number and zygosity in transgenic plants
  Plant Cell Reports, 2004
• The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis
  Schizophrenia Research, 2003
• Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group
  Schizophrenia Research, 2003
• Genomic Control for Association Studies
  Biometrics, 1999
• Use of Unlinked Genetic Markers to Detect Population Stratification in Association Studies
  The American Journal of Human Genetics, 1999